Galmed Pharma (GLMD) Tops Q3 EPS by 6c

Galmed Pharma (NASDAQ: GLMD) reported Q3 EPS of ($0.23), $0.06 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• Analysts eye Intuit investor day for signs estimates have troughed
• Halozyme prices $1.3B convertible notes offering due 2033